U.S., June 10 -- ClinicalTrials.gov registry received information related to the study (NCT07635966) titled 'An Extension Study of EV-BR1701 Part A1' on May 28.
Brief Summary: To determine the long-term immunogenicity more than 5 years after EnVAX-A71 vaccination in the pediatric population aged 2 months to <6 years when first vaccinated.
Study Start Date: Sept. 20, 2025
Study Type: OBSERVATIONAL
Condition:
Enterovirus Infections
Recruitment Status: COMPLETED
Sponsor: Enimmune Corporation
Published by HT Digital Content Services with permission from Health Daily Digest....